SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

3 Months Ended

Jul. 01, 2023

Selected Information by Business Segment

Selected information by reportable segment is presented below:


	Three Months Ended
(In thousands)	July 1, 2023		July 2, 2022
Net revenues
Plasma	$	138,482	$	103,042
Blood Center	67,306		66,573
Hospital	99,536		89,184
Net revenues by business unit	305,324		258,799
Service (1)	5,764		5,137
Effect of exchange rates	244		(2,478)
Net revenues	$	311,332	$	261,458
(1) Reflects revenue for service, maintenance and parts


	Three Months Ended
(In thousands)	July 1, 2023		July 2, 2022
Segment operating income
Plasma	$	75,698	$	55,126
Blood Center	26,283		30,377
Hospital	40,943		34,722
Segment operating income	142,924		120,225
Corporate expenses (1)	(75,309)		(81,584)
Effect of exchange rates	2,613		6,245
Integration and transaction costs	(1,115)		758
Amortization of acquired intangible assets	(7,473)		(8,367)
Restructuring costs	11		44
Restructuring related costs	(2,204)		(3,522)
Digital transformation costs	(3,705)		—
Impairment of assets and PCS2 related charges	141		350
MDR and IVDR costs	(1,166)		(3,186)
Litigation-related charges	(1,058)		(196)

Operating income	$	53,659	$	30,767
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.

Schedule of Revenues by Business Unit and Geographic Regions

Management reviews revenue based on the reportable segments noted above. Although these reportable segments are primarily product-based, they differ from the Company’s product line revenues for Plasma products and services and Blood Center products and services. Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes. Additionally, product line revenues also include service revenues which are excluded from the reportable segments.

Net revenues by business unit are as follows:


		Three Months Ended
(In thousands)		July 1, 2023		July 2, 2022
	Plasma	$	138,610	$	102,381

	Whole Blood	20,040		19,595
	Apheresis	47,300		46,099
	Blood Center	67,340		65,694

	Hemostasis Management	37,820		33,497
	Vascular Closure	37,620		29,568
	Other(1)	24,168		25,429
	Hospital	99,608		88,494

Net business unit revenues		305,558		256,569
	Service	5,774		4,889
Net revenues		$	311,332	$	261,458
(1) Other includes the Cell Salvage and Transfusion Management product lines of the Hospital business unit.

Net revenues generated in the Company’s principle operating regions on a reported basis are as follows:


	Three Months Ended
(In thousands)	July 1, 2023		July 2, 2022
United States	$	237,073	$	181,996
Japan	11,773		13,878
Europe	39,387		40,457
Rest of Asia	22,040		24,424
Other	1,059		703
Net revenues	$	311,332	$	261,458